Fujitsu Limited and IBM Japan, Ltd. today announced that they will accelerate their collaboration in the field of business system modernization in order to advance enterprise digital transformation ...

Everyone already knows that Todd Monken loves to run the football and that he’s been insanely effective at it. What most people overlook is how he’s able to be so consistently good at it. It’s not ...

I read your response to the woman who wondered why she should invest in Social Security when the stock market would have been far more lucrative (“If I had invested my Social Security in the S&P 500 I ...

HONOLULU (KHON2) — Running for office in Hawaiʻi is a rather simple process, outside of the campaign itself. There are minimum requirements and fees that don’t create barriers for anyone who wants to ...

Take a group of runners circling a track at unique, constant paces. Answering the question of how many will always end up running alone, no matter their speed, has vexed mathematicians for decades.

BRUSSELS, April 14, 2026 (GLOBE NEWSWIRE) -- The Eclipse Foundation today announced the Open VSX Security Researcher Recognition Program, a new initiative designed to strengthen the security of the ...

While learning how to run easy might sound, well, easy, it’s actually a lot harder than it sounds. Yet, it’s key to progressing, says URUNN coach Charlotte Purdue. And as the current British Marathon ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

A rare atmospheric effect called selenelion could briefly let skywatchers see the rising sun and a blood moon at the same time. When you purchase through links on our site, we may earn an affiliate ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Amgen’s decision to terminate its rocatinlimab collaboration with Kyowa Kirin follows the publication of data on Sanofi’s rival OX40 drug candidate amlitelimab. (iStock / Getty Images Plus) Amgen has ...